Turkey Blood Bags Market to Grow with a CAGR of 5.45% through 2030

Growing Number of Accidental Cases and Rising Prevalence of Chronic Diseases is expected to drive the Turkey Blood Bags Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Turkey Blood Bags Market – By Region, Competition, Forecast & Opportunities, 2030F”, the Turkey Blood Bags Market stood at USD 28.25 Million in 2024 and is anticipated to grow with a CAGR of 5.45% in the forecast period, 2026-2030.

The Turkish government has intensified its commitment to modernizing the healthcare sector through the Health Transformation Program. This initiative has led to the rapid development and expansion of state-of-the-art hospitals, diagnostic centers, and clinical facilities. The push toward improved healthcare delivery has directly increased the need for safe, efficient, and standardized blood collection and transfusion systems. This systemic upgrade has established a consistent and scalable demand for blood bags across public and private healthcare institutions, driving bulk procurement contracts and increasing volumes for both domestic suppliers and international distributors. The rising number of surgical procedures, driven by population aging, road traffic accidents, and broader access to advanced medical care, has resulted in a sharp uptick in transfusion requirements. Whether for emergency trauma care or elective surgeries, blood component therapy has become integral to post-operative patient management. This has led to predictable, high-frequency orders of single, double, and multi-bag systems from surgical and trauma departments, encouraging suppliers to offer flexible, contract-based fulfillment models for large healthcare providers.

Efforts by the Turkish Red Crescent and other NGOs to cultivate a culture of voluntary blood donation have gained considerable traction. Public awareness campaigns, mobile blood collection units, and community engagement programs have increased the size and consistency of Turkey’s active donor base. With regular donation drives becoming institutionalized, demand for sterile, pre-sterilized blood bags with integrated anticoagulants has grown. This trend supports recurring revenue streams for manufacturers and importers focused on quality-assured, disposable blood collection systems. Turkey is witnessing a notable rise in non-communicable diseases, particularly cancer, renal failure, and blood disorders such as thalassemia and anemia. These conditions often necessitate frequent and long-term transfusion therapies, placing sustained pressure on transfusion infrastructure. Healthcare providers, especially oncology units and dialysis centers, are driving continuous demand for high-reliability blood bags. This pattern supports the development of product differentiation strategies focusing on durability, contamination prevention, and precise labeling systems.

The alignment of Turkey’s medical regulations with European Union (EU) standards, including mandates for CE-marked products, has elevated the compliance threshold for blood bags and other critical consumables. Government support in the form of procurement guidelines and quality assurance protocols has reinforced this trend. These standards create a more competitive environment that favors quality-focused manufacturers, both domestic and foreign, and facilitate export-readiness for Turkish suppliers targeting international markets with globally certified products. Turkey has become a preferred destination for medical tourism, especially for cosmetic surgery, orthopedics, organ transplants, and cardiac procedures. Many of these treatments require perioperative blood transfusions, increasing hospital-level demand for transfusion consumables. The influx of international patients has transformed private healthcare providers into high-volume consumers of blood bags. This presents lucrative opportunities for suppliers offering premium, high-quality products tailored to institutions serving medical tourists.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Turkey Blood Bags Market”

The Turkey Blood Bags Market is segmented into product type, type, volume, material, end user, regional distribution, and company.

Based on its end user, the Hospitals segment has emerged as the predominant market leader, Vietnam's healthcare sector, Hospitals both public and private serve as the central hubs for emergency care, surgical interventions, trauma management, oncology treatments, and intensive care services, all of which routinely rely on blood transfusions. Given the scale and complexity of operations in secondary and tertiary care facilities, hospitals require a continuous and diversified supply of blood bags, including single, double, triple, and quadruple bag systems for component separation.

High transfusion volumes due to the treatment of chronic diseases such as cancer, renal failure, and blood disorders. Trauma and surgical departments generate predictable demand, particularly in urban hospitals dealing with accident cases and elective surgeries. Integration with blood banks within large hospitals increases the need for blood collection and storage solutions on-site. Hospital consolidation and infrastructure expansion under public-private partnership (PPP) models have increased procurement volumes. This segment accounts for a significant portion of recurring orders in the market, often under long-term procurement contracts. Manufacturers and suppliers focus heavily on hospitals due to the scale of consumption, reliability of demand, and opportunities for bulk supply agreements, making this segment commercially critical.

Major companies operating in Turkey Blood Bags Market are:

• Terumo BCT Turkey
• Gazi Group
• Lmb Technologie GmbH
• Kızılay Biomedical
• Ermed Tıp Medikal A.Ş
• ERENLER MEDİKAL SAN. TİC. LTD. ŞTİ.
• Kansuk İlaç
• InstaMed Medical Equipment Trading LLC

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Turkey blood bags market is positioned for sustained growth, supported by a strong healthcare infrastructure, rising clinical demand for blood transfusions, and increasing adoption of advanced transfusion technologies. With hospitals leading in consumption and government initiatives promoting voluntary donations and quality compliance, the market presents substantial opportunities for both domestic manufacturers and international suppliers. However, to capitalize on this potential, stakeholders must strategically address regulatory requirements, supply chain dynamics, and evolving end-user preferences. As healthcare modernization continues and medical tourism expands, Turkey is expected to remain a key regional hub for blood bag demand in the coming years.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Turkey Blood Bags Market, By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag, Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Turkey Blood Bags Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Turkey Blood Bags Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com